A detailed history of Virtu Financial LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 21,713 shares of VNDA stock, worth $103,788. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,713
Previous 65,148 66.67%
Holding current value
$103,788
Previous $368,000 72.28%
% of portfolio
0.01%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$4.61 - $6.34 $200,235 - $275,377
-43,435 Reduced 66.67%
21,713 $102,000
Q2 2024

Aug 09, 2024

BUY
$3.91 - $6.5 $71,079 - $118,163
18,179 Added 38.7%
65,148 $368,000
Q1 2024

May 20, 2024

BUY
$3.47 - $4.61 $162,982 - $216,527
46,969 New
46,969 $193,000
Q2 2021

Sep 17, 2021

SELL
$15.71 - $21.51 $159,330 - $218,154
-10,142 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$13.42 - $20.28 $136,105 - $205,679
10,142 New
10,142 $152,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $270M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.